Structural basis of second-generation HIV integrase inhibitor action and viral resistance
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Strengths and weaknesses of an HIV drug: Retroviruses replicate by inserting a copy of their RNA, which has been reverse transcribed into DNA, into the host genome. This process involves the intasome, a nucleoprotein complex comprising copies of the viral integrase bound at the ends of the viral DNA. HIV integrase strand-transfer inhibitors (INSTIs) stop HIV from replicating by blocking the viral integrase and are widely used in HIV treatment. Cook et al. describe structures of second-generation inhibitors bound to the simian immunodeficiency virus (SIV) intasome and to an intasome with integrase mutations known to cause drug resistance. Passos et al. describe the structures of the HIV intasome bound to a second-generation inhibitor and to developmental compounds that are promising drug leads. These structures show how mutations can cause subtle changes in the active site that affect drug binding, show the basis for the higher activity of later-generation inhibitors, and may guide development of better drugs. Science , this issue p. 806 , p. 810
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with their function, all intasomes feature 2-fold symmetry and harbour a pair of juxtaposed active sites engaged with 3’ vDNA ends.”
From Structure and function of retroviral integrase (2022) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite these differences, all intasomes incorporate the conserved intasome core (CIC) assembly, which is the minimal functional unit and is represented by the PFV structure (Figs. 2A, 3).”
From Structure and function of retroviral integrase (2022) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The structures revealed unexpected architectural diversity among intasomes from different retroviral genera.”
From Structure and function of retroviral integrase (2022) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The stoichiometric state of primate lentiviral intasomes from HIV-1 and the simian immunodeficiency virus (SIV) remain a subject of debate, with complexes containing four and eight to sixteen IN molecules observed by cryo-EM and negative stain electron microscopy33–36.”
From Structure and function of retroviral integrase (2022) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, LEDGF/p75 was instrumental to reconstitute lentiviral intasomes for structural characterisation32–36.”
From Structure and function of retroviral integrase (2022) · cites this paper as [35]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Density-functional thermochemistry. III. The role of exact exchange
Becke, A. D. (1993) · The Journal of Chemical Physics · doi:10.1063/1.464913 · Cited by 103,767
Weigend, F., & Ahlrichs, R. (2005) · Physical Chemistry Chemical Physics · doi:10.1039/b508541a · Cited by 30,598
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Development and testing of a general amber force field
Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20035 · Cited by 19,506
Intermolecular interactions from a natural bond orbital, donor-acceptor viewpoint
Reed, A. E., Curtiss, L. A., & Weinhold, F. (1988) · Chemical Reviews · doi:10.1021/cr00088a005 · Cited by 17,359
Scalable molecular dynamics with NAMD
Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kalé, L., & Schulten, K. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20289 · Cited by 16,914
Hehre, W. J., Ditchfield, R., & Pople, J. A. (1972) · The Journal of Chemical Physics · doi:10.1063/1.1677527 · Cited by 15,855
Long-range corrected hybrid density functionals with damped atom–atom dispersion corrections
Chai, J.-D., & Head-Gordon, M. (2008) · Physical Chemistry Chemical Physics · doi:10.1039/b810189b · Cited by 14,648
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Punjani, A., Rubinstein, J. L., Fleet, D. J., & Brubaker, M. A. (2017) · Nature Methods · doi:10.1038/nmeth.4169 · Cited by 11,626
Ditchfield, R., Hehre, W. J., & Pople, J. A. (1971) · The Journal of Chemical Physics · doi:10.1063/1.1674902 · Cited by 10,612
Cited by
Zhao, A., Crutchley, R. D., Guduru, R. C., Ton, K., Lam, T., & Min, A. (2022) · Retrovirology · doi:10.1186/s12977-022-00608-1 · Cited by 156
Structure and function of retroviral integrase
Maertens, G. N., Engelman, A. N., & Cherepanov, P. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00586-9 · Cited by 124
Self-citationIntegrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs
Smith, S. J., Zhao, X. Z., Passos, D. O., Lyumkis, D., Burke, T. R., & Hughes, S. H. (2021) · Viruses · doi:10.3390/v13020205 · Cited by 131
“Structural analyses of DTG bound to the active SIVrcm IN have pointed to the importance of the oxazine ring (the “A” ring, which is the ring system farthest from the halobenzyl group; Figure S1, black circle) [26].”
BackgroundMethodInfluentialMbhele, N., Chimukangara, B., & Gordon, M. L. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106343 · Cited by 109
Cryo-EM as a powerful tool for drug discovery
Drie, J. H. V., & Tong, L. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127524 · Cited by 101
Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond
Matthew, A. N., Leidner, F., Lockbaum, G. J., Henes, M., Zephyr, J., Hou, S., Rao, D. N., Timm, J., Rusere, L. N., Ragland, D. A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00648 · Cited by 101
Rotten to the core: antivirals targeting the HIV-1 capsid core
McFadden, W. M., Snyder, A. A., Kirby, K. A., Tedbury, P. R., Raj, M., Wang, Z., & Sarafianos, S. G. (2021) · Retrovirology · doi:10.1186/s12977-021-00583-z · Cited by 73
Li, W., Singh, P. K., Sowd, G. A., Bedwell, G. J., Jang, S., Achuthan, V., Oleru, A. V., Wong, D., Fadel, H. J., Lee, K., et al. (2020) · mBio · doi:10.1128/mbio.02254-20 · Cited by 64
“Concentrations of retroviral particles in mU/ml were determined using a TaqMan-based product-enhanced reverse transcriptase (Taq-PERT) real-time PCR assay (80).”
Self-citationStructural Biology of HIV Integrase Strand Transfer Inhibitors
Jozwik, I. K., Passos, D. O., & Lyumkis, D. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.06.003 · Cited by 78
Xu, C., Ke, Z., Liu, C., Wang, Z., Liu, D., Zhang, L., Wang, J., He, W., Xu, Z., Li, Y., et al. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00821 · Cited by 55
“They are structurally related as the former is a derivation from the latter (75).”
BackgroundCabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV
Taki, E., Soleimani, F., Asadi, A., Ghahramanpour, H., Namvar, A., & Heidary, M. (2022) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2022.2081153 · Cited by 59
Li, M., Oliveira Passos, D., Shan, Z., Smith, S. J., Sun, Q., Biswas, A., Choudhuri, I., Strutzenberg, T. S., Haldane, A., Deng, N., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg5953 · Cited by 39
Berta, D., Buigues, P. J., Badaoui, M., & Rosta, E. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.01.002 · Cited by 37
Self-citationStrategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges
Yoder, K. E., Rabe, A. J., Fishel, R. A., & Larue, R. C. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.662331 · Cited by 41
Multimodal Functionalities of HIV-1 Integrase
Engelman, A., & Kvaratskhelia, M. (2022) · Viruses · doi:10.3390/v14050926 · Cited by 41
“Lentiviral intasomes have revealed more diverse structures, which range from IN tetramers to hexadecamers [76,91]; the field consensus is that the higher-order structures likely represent the physiological arrangement of lentiviral IN on vDNA [92,93] (Figure 3).”
BackgroundSelf-citationLong Dissociation of Bictegravir from HIV-1 Integrase-DNA Complexes
White, K. L., Osman, N., Cuadra-Foy, E., Brenner, B. G., Shivakumar, D., Campigotto, F., Tsiang, M., Morganelli, P. A., Novikov, N., Lazerwith, S. E., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02406-20 · Cited by 33
“Structural studies of the INSTI interactions with integrase intasomes (2, 12, 20, 21) and our models show that BIC forms a stable complex with HIV-1 IN bound to HIV-1 long-terminalrepeat DNA.”
BackgroundMethodInfluentialEltrombopag is a potential target for drug intervention in SARS-CoV-2 spike protein
Feng, S., Luan, X., Wang, Y., Wang, H., Zhang, Z., Wang, Y., Tian, Z., Liu, M., Xiao, Y., Zhao, Y., et al. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104419 · Cited by 33
Targeting Metalloenzymes by Boron-Containing Metal-Binding Pharmacophores
Xiao, Y., Yu, J., Dai, Q.-Q., Li, G., & Li, G. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01691 · Cited by 33
Biktarvy for the treatment of HIV infection: Progress and prospects
Clercq, E. D., Zhang, Z., Huang, J., Zhang, M., & Li, G. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115862 · Cited by 36
Fluorine in anti-HIV drugs approved by FDA from 1981 to 2023
Han, S., & Lu, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115586 · Cited by 30
HIV-1 Integrase Inhibitors That Are Active against Drug-Resistant Integrase Mutants
Smith, S. J., Zhao, X. Z., Passos, D. O., Lyumkis, D., Burke, T. R., & Hughes, S. H. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00611-20 · Cited by 32
“As recently suggested in the context of SIVrcm, the E138T substitution causes H114 to donate a proton to the substituted G140S, making S140 a hydrogen bond donor for its interaction with H148, which is expected to enhance resistance (34).”
BackgroundInfluentialAdvances in the development of HIV integrase strand transfer inhibitors
Wang, Y., Gu, S., He, Q., & Fan, R. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113787 · Cited by 29
Identification of Entry Inhibitors against Delta and Omicron Variants of SARS-CoV-2
Lee, R. K., Li, T., Chang, S., Chao, T., Kuo, C.-H., Pan, M. Y.-C., Chiou, Y.-T., Liao, K.-J., Yang, Y., Wu, Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23074050 · Cited by 28
“Interestingly, both drugs were initially designed for the treatment of human immunodeficiency virus (HIV).”
BackgroundInfluentialThe Effect of Treatment-Associated Mutations on HIV Replication and Transmission Cycles
Johnson, M. M., Jones, C. E., & Clark, D. N. (2022) · Viruses · doi:10.3390/v15010107 · Cited by 34
“For example, a mechanism of resistance at Q148 has been described, where the substitution displaces a critical water molecule that helps coordinate both D116 and E152 active site residues; this in turn changes the charge and interaction with the critical Mg2+ ion, allowing catalysis despite the presence of inhibitors…”
BackgroundLong-Acting Cabotegravir for HIV/AIDS Prophylaxis
Engelman, K. D., & Engelman, A. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00157 · Cited by 27
Self-citationXiao, M. A., Cleyle, J., Yoo, S., Forrest, M., Krullaars, Z., Pham, H. T., & Mésplède, T. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01386-22 · Cited by 23
“virus (SIV) of the red-capped mangabeys (5).”
Multivalent interactions essential for lentiviral integrase function
Ballandras-Colas, A., Chivukula, V., Gruszka, D. T., Shan, Z., Singh, P. K., Pye, V. E., McLean, R. K., Bedwell, G. J., Li, W., Nans, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29928-8 · Cited by 25
“CTD dimerization is conserved among lentiviral INs (1,13,17,37), although further multimerization into the tetrad has thus far been observed only for MVV IN in the context of the vDNA-bound intasome (1).”
BackgroundMethodInfluentialSelf-citationThe Drug-Induced Interface That Drives HIV-1 Integrase Hypermultimerization and Loss of Function
Singer, M. R., Dinh, T., Levintov, L., Annamalai, A. S., Rey, J. S., Briganti, L., Cook, N., Pye, V. E., Taylor, I. A., Kim, K., et al. (2023) · mBio · doi:10.1128/mbio.03560-22 · Cited by 21
Self-citationSmith, S. J., Zhao, X. Z., Passos, D. O., Pye, V. E., Cherepanov, P., Lyumkis, D., Burke, T. R., & Hughes, S. H. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00819 · Cited by 22
Self-citationLi, M., Yang, R., Chen, X., Wang, H., Ghirlando, R., Dimitriadis, E. K., & Craigie, R. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168557 · Cited by 18
“16 With hindsight, it should have been apparent that the tetrameric PFV intasome structure disproved this idea.”
BackgroundBiswas, A., Choudhuri, I., Arnold, E., Lyumkis, D., Haldane, A., & Levy, R. M. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2316662121 · Cited by 19
“The mechanism of resistance for Q148H can be explained by the introduction of an electropositive moiety underneath the two Mg 2+ metal ions, weakening metal chelation and leading to INSTI displacement (53, 60).”
BackgroundBarski, M. S., Vanzo, T., Zhao, X. Z., Smith, S. J., Ballandras-Colas, A., Cronin, N., Pye, V. E., Hughes, S. H., Burke, T. R., Cherepanov, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25284-1 · Cited by 20
“For the expression of LEDGF/ΔIBDB56γ, the previously described pET28a(+)SUMO-H6P-LEDGF/ΔIBDPPP2R5C(11-380) construct was used9.”
BackgroundSelf-citationRetroviral integrase: Structure, mechanism, and inhibition
Passos, D. O., Li, M., Craigie, R., & Lyumkis, D. (2021) · The Enzymes · doi:10.1016/bs.enz.2021.06.007 · Cited by 22
“Both the second generation INSTIs and the developmental naphthyridine compounds have made use of some of this space, and their increased potency can be in part attributed to the additional interactions made in this general area [161,162].”
BackgroundInfluentialThe C-Terminal Domain of HIV-1 Integrase: A Swiss Army Knife for the Virus?
Rocchi, C., Gouet, P., Parissi, V., & Fiorini, F. (2022) · Viruses · doi:10.3390/v14071397 · Cited by 19
B-to-A transition in target DNA during retroviral integration
Jozwik, I. K., Li, W., Zhang, D., Wong, D., Grawenhoff, J., Ballandras-Colas, A., Aiyer, S., Cherepanov, P., Engelman, A., & Lyumkis, D. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac644 · Cited by 18
“MMTV concentration in mU/ml was determined using a TaqMan-based product-enhanced exogenous reverse transcriptase (RT) assay as described (16).”
MethodSelf-citationLao, X., Zhang, H., Deng, M., Li, Q., Xiao, Q., He, L., Ma, L., Song, A., Liang, X., Yu, F., et al. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-023-08906-5 · Cited by 15
“However, the persistence of LLV, although at a lower rate, revealed that integrase inhibitors are not entirely successful in achieving complete viral eradication [24].”
BackgroundAl-Otaibi, J. S., Almuqrin, A. H., Mary, Y. S., Mary, Y. S., & Thomas, R. (2020) · Polycyclic aromatic compounds · doi:10.1080/10406638.2020.1827270 · Cited by 15
Cryo-EM structure of the Rous sarcoma virus octameric cleaved synaptic complex intasome
Pandey, K. K., Bera, S., Shi, K., Rau, M. J., Oleru, A. V., Fitzpatrick, J. A. J., Engelman, A. N., Aihara, H., & Grandgenett, D. P. (2021) · Communications Biology · doi:10.1038/s42003-021-01855-2 · Cited by 14
Self-citationDolutegravir induces FOLR1 expression during brain organoid development
Caiaffa, C. D., Tukeman, G. L., Delgado, C. Z., Ambekar, Y. S., Mekonnen, T. T., Singh, M., Rodriguez, V., Ricco, E., Kraushaar, D. C., Aglyamov, S. R., et al. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1394058 · Cited by 15
Isaacs, D., Mikasi, S. G., Obasa, A. E., Ikomey, G. M., Shityakov, S., Cloete, R. E. A., & Jacobs, G. B. (2020) · Viruses · doi:10.3390/v12090936 · Cited by 14
GOLEM: Automated and Robust Cryo-EM-Guided Ligand Docking with Explicit Water Molecules
Zhao, Z., & Tajkhorshid, E. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00917 · Cited by 14
Imamichi, T., Bernbaum, J. G., Laverdure, S., Yang, J., Chen, Q., Highbarger, H., Hao, M., Sui, H., Dewar, R. L., Chang, W., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01323-21 · Cited by 12
“Crystal analysis of the full-length of GagPol even an enter length of IN 193 was not completed due to disorder at the C terminus domain of IN and unclear in the resulting 194 crystal structure; instead, many partial structure analyses were conducted (31-35); thus, we 195 attempted to perform in silico Structure analys…”
BackgroundMethodSingh, P., Li, W., Bedwell, G., Fadel, H., Poeschla, E., & Engelman, A. (2022) · Viruses · doi:10.3390/v14091883 · Cited by 13
“To determine dose response curves as a function of host factor content, BI-D or dimethyl sulfoxide (DMSO) was added to triplicate wells at the time of HEK293T cell infection essentially as described for a prior INSTI study [75].”
MethodSelf-citationSayyed, S. K., Quraishi, M., Jobby, R., Rameshkumar, N., Kayalvizhi, N., Krishnan, M., & Sonawane, T. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03461-8 · Cited by 15
“The combinations of these mutations along with accessory mutations can lead to a greater reduction in drug susceptibility representing a threat to the ARV drug’s long-term efficacy (Brooks et al. 2019; Cook et al. 2020; Smith et al. 2021a).”
BackgroundInfluentialLi, M., Li, Z., Chen, X., Cui, Y., Engelman, A. N., & Craigie, R. (2024) · Viruses · doi:10.3390/v16071166 · Cited by 12
“Heterointasomes were assembled by mixing full-length Sso7d-IN, His-tagged CTD, and vDNA, essentially as depicted in Figure 1C. Previous lentiviral intasome studies have leveraged the IN host cofactor lens epithelium-derived growth factor (LEDGF) [6,8–11 , 17 ].”
BackgroundMethodInfluentialSelf-citationOrtega, J. A., Sasselli, I. R., Boccitto, M., Fleming, A. C., Fortuna, T. R., Li, Y., Sato, K., Clemons, T. D., McKenna, E. D., Nguyen, T. P., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf7997 · Cited by 16
Pham, H. T., Alves, B. M., Yoo, S., Xiao, M. A., Leng, J., Quashie, P. K., Soares, E. A., Routy, J., Soares, M. A., & Mésplède, T. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa471 · Cited by 12
Hazards of antiviral contamination in water: Dissemination, fate, risk and their impact on fish
Choudhury, A., Ojha, P. K., & Ray, S. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.135087 · Cited by 11
Engelman, A., & Cherepanov, P. (2020) · FEBS Journal · doi:10.1111/febs.15438 · Cited by 12
Self-citationInfluence of the amino-terminal sequence on the structure and function of HIV integrase
Eilers, G., Gupta, K., Allen, A., Zhou, J. O., Hwang, Y., Cory, M., Bushman, F. D., & Duyne, G. D. V. (2020) · Retrovirology · doi:10.1186/s12977-020-00537-x · Cited by 11
Acosta, R. K., D’Antoni, M. L., Mulato, A. S., Yant, S. R., Cihlář, T., & White, K. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02038-21 · Cited by 12
IS21 family transposase cleaved donor complex traps two right-handed superhelical crossings
Spínola‐Amilibia, M., Araújo‐Bazán, L., de la Gándara, Á., Berger, J. M., & Arias‐Palomo, E. (2023) · Nature Communications · doi:10.1038/s41467-023-38071-x · Cited by 20
Molecular basis for transposase activation by a dedicated AAA+ ATPase
de la Gándara, Á., Spínola‐Amilibia, M., Araújo‐Bazán, L., Núñez‐Ramírez, R., Berger, J. M., & Arias‐Palomo, E. (2024) · Nature · doi:10.1038/s41586-024-07550-6 · Cited by 13
“The presence of a β-barrel adjacent to a trans-posase DDE domain has been described for systems such as TnsB and MuA (in these proteins it is often referred to as domain IIβ), as well as for retroviral integrases 36,37,51,52 .”
HIV integrase inhibitors that inhibit strand transfer interact with RAG1 and hamper its activities
Nilavar, N. M., & Raghavan, S. C. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107515 · Cited by 9
Hikichi, Y., Burdick, R. C., Patro, S. C., Ding, S.-Y., Luke, B. T., Clark, E., Ablan, S. D., Wu, X., Pathak, V. K., & Freed, E. O. (2025) · Science Advances · doi:10.1126/sciadv.adz8980 · Cited by 12
“Because INSTIs act by binding the intasome—a complex of newly synthesized and 3 ′ processed viral DNA ends and a multimer of IN ( 5 , 7 , 8 )—reducing the time be-tween viral DNA end formation and integration would effectively narrow the window of time available for INSTIs to bind the inta-some and…”
Integrase anchors viral RNA to the HIV-1 capsid interior
Singer, M. R., Li, Z., Rey, J. S., Hope, J., Chenavier, F., Cook, N., Punch, E. K., Smith, J., Zhou, Z., Maslen, S., et al. (2026) · Nature · doi:10.1038/s41586-026-10154-x · Cited by 11
Self-citationWang, Y., Zhang, W., Zhang, R., Chen, G., Chen, T., Xiong, Q.-Q., Liu, C., Zhao, Y.-L., Li, Y.-J., Liao, S., et al. (2023) · Molecules · doi:10.3390/molecules28248020 · Cited by 10
“Chelating with the metal ions of integrase is critical for INSTIs [27,36], and compounds with obvious metal chelating properties and novel structural scaffolds were retained.”
BackgroundInfluentialZhang, R., Chen, G., Wang, W., Wang, Y., Zhang, W., Chen, T., Xiong, Q.-Q., Zhao, Y., Liao, S., Li, Y., et al. (2024) · RSC Advances · doi:10.1039/d3ra08320a · Cited by 8
Jing, T., Shan, Z., Dinh, T., Biswas, A., Jang, S., Greenwood, J., Li, M., Zhang, Z., Gray, G., Shin, H. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64479-8 · Cited by 17
“The pleiotropic nature of lentiviral IN/ intasomes is well-established 8,10,12,19 .”
Self-citationBrief Histories of Retroviral Integration Research and Associated International Conferences
Grandgenett, D. P., & Engelman, A. (2024) · Viruses · doi:10.3390/v16040604 · Cited by 8
“…studies of HIV-1 intasomes, as well as of intasomes from the more closely related simian immunodeficiency virus from red-capped mangabeys, were necessary to fine-tune INSTI-IN active-site interactions, especially as they pertain to second-generation INSTI compounds (Figure 4) [90,127,128].”
BackgroundSelf-citationSun, Q., Biswas, A., Lyumkis, D., Levy, R., & Deng, N. (2024) · Viruses · doi:10.3390/v16010076 · Cited by 6
“These insights will extend to the development of third-generation INSTIs [11,26,33].”
BackgroundAn Update on Antiretroviral Therapy
Menéndez‐Arias, L., Martín-Alonso, S., & Frutos-Beltrán, E. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-0267-2_2 · Cited by 9
A medicinal chemistry overview of direct-acting antivirals approved in 2013–2024 by US FDA
Nizi, M. G., Massari, S., Tabarrini, O., & Manfroni, G. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118105 · Cited by 11
Mahajan, P. S., Smith, S. J., Hughes, S. H., Zhao, X. Z., & Burke, T. R. (2023) · Molecules · doi:10.3390/molecules28031428 · Cited by 5
“Although such INSTIs have been developed empirically, a rationale for the potential roles played by this functionality is beginning to emerge from high resolution structures of INSTIs bound to intasomes, where it is found that this region of the INSTI contacts the β4-α2 loop of IN and helps the compounds retain better…”
BackgroundCardoza, S., Yadav, P., Ajmani, A., Das, P., & Tandon, V. (2023) · ACS Omega · doi:10.1021/acsomega.2c07372 · Cited by 5
Mahajan, P. S., Smith, S. J., Li, M., Craigie, R., Hughes, S. H., Zhao, X. Z., & Burke, T. R. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00525 · Cited by 7
Modulation of the functional interfaces between retroviral intasomes and the human nucleosome
Mauro, E., Lapaillerie, D., Tumiotto, C., Charlier, C., Martins, F. G., Sousa, S. F., Métifiot, M., Weigel, P., Yamatsugu, K., Kanai, M., et al. (2023) · mBio · doi:10.1128/mbio.01083-23 · Cited by 6
Machado, L. D. A., & Guimarães, A. C. R. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00170 · Cited by 8
“The INSTIs are divided into two generations: the first, which includes Raltegravir (RAL) and Elvitegravir (EVG); and the second, represented by Dolutegravir (DTG) and more recently Bictegravir (BIC) (Fesen et al., 1993; Evering and Markowitz, 2007; Shimura and Kodama, 2009; Blanco et al., 2011; Pendri et al., 2011; Ak…”
BackgroundInfluentialWan, Z., Shi, M., Gong, Y., Lucci, M., Li, J., Zhou, J., Yang, X., Lelli, M., He, X. D., & Mao, J. (2024) · Molecules · doi:10.3390/molecules29020376 · Cited by 4
“Even at such low bioavailable concentrations, this drug still shows excellent HIV inhibition potency due to its high efficacy (with an IC 50 at 0.5 nM in the pseudotyped virus assay) [12,13].”
BackgroundInfluentialDiscovery of Dolutegravir Derivative against Liver Cancer via Inducing Autophagy and DNA Damage
Hou, X., Yan, D. M., Wu, Z., Mao, L., Wang, H., Guo, Y., & Yang, J. (2024) · Molecules · doi:10.3390/molecules29081779 · Cited by 4
“…that DTG is better than a control drug in the treatment of HIV first-infected people and has better effect on patients who failed treatment without use of integrase Good responses were also found in adult patients who were resistant to raltegravir (RAL) or elvitegravir (EVG) [14,15]. inhibitors.”
BackgroundDemirdjian, S., Duong, V. N., Byrum, J. N., Nayak, A., McKinney, C. B., Perry, J. K., Callebaut, C., Rodgers, K. K., Falkard, B., & Feng, J. Y. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.02468-24 · Cited by 4
Jing, T., Shan, Z., Dinh, T., Biswas, A., Jang, S., Greenwood, J., Li, M., Zhang, Z., Gray, G., Shin, H. J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.26.577436 · Cited by 4
Self-citationJaryal, R., & Khan, S. A. (2023) · BioMetals · doi:10.1007/s10534-023-00498-6 · Cited by 3
“Nowadays instasomes are targeted by the lat-est generation of integrase strand-transfer inhibitors (INSTIs) drugs (Grawenhoff and Engelman 2017; Cook et al. 2020).”
BackgroundDNA strand breaks and gaps target retroviral intasome binding and integration
Senavirathne, G., London, J. A., Gardner, A., Fishel, R. A., & Yoder, K. E. (2023) · Nature Communications · doi:10.1038/s41467-023-42641-4 · Cited by 4
Kiarie, I. W., Hoffka, G., Laporte, M., Leyssen, P., Neyts, J. H., Tőzsér, J., & Mahdi, M. (2024) · Viruses · doi:10.3390/v16101607 · Cited by 3
“Structural analysis suggests that the active site Mg 2+ ions have a crucial role in inhibitor binding, forming interactions that were described as almost covalent between bictegravir and the SIVrcm integrase [67].”
BackgroundResultInfluentialMolecular determinants for Rous sarcoma virus intasome assemblies involved in retroviral integration
Bera, S., Shi, K., Aihara, H., Grandgenett, D. P., & Pandey, K. K. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104730 · Cited by 2
“Similar to wt IN (1-286), all of these IN mutants were dimeric (Fig.”
BackgroundMethodInfluentialSmith, S. J., Zhao, X. Z., Hughes, S. H., & Burke, T. R. (2025) · Viruses · doi:10.3390/v17010121 · Cited by 2
“Recent work has shed light on mechanisms of resistance when mutations occur at IN positions E138K, G140A/S, and Q148H/K/R in both SIVrcm IN and HIV-1 IN [26,27].”
Evolutionary Sequence and Structural Basis for the Epistatic Origins of Drug Resistance in HIVPreprint
Biswas, A., Choudhuri, I., Huang, K., Sun, Q., Šali, A., Echeverria, I., Haldane, A., Levy, R. M., & Lyumkis, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.30.651576 · Cited by 2
QM/MM free energy calculations for enzyme catalytic reactions
Rosta, E. (2025) · Advances in quantum chemistry · doi:10.1016/bs.aiq.2025.03.003 · Cited by 1
Self-citationEfficient Production of (R)-3-Aminobutyric Acid by Biotransformation of Recombinant E. coli
Zhang, H., Xu, Q. C., Lv, J., Zhang, J., Dou, T., You, S., Su, R., & Qi, W. D. (2025) · Catalysts · doi:10.3390/catal15050466 · Cited by 1
Predicting water at the protein interface in cryo-EM structures from MD-excess chemical potential
Sun, Q., Aiyer, S., Biswas, A., Haldane, A., Chatterjee, S., Matubayasi, N., Lyumkis, D., & Levy, R. M. (2026) · Biophysical Journal · doi:10.1016/j.bpj.2026.01.043 · Cited by 1
“For example, displacement of waters bound within the active site of lentiviral integrases has been proposed to be the initiating step for a key mechanism of drug resistance (5,6).”
Tereshkina, A. A., Viktorova, V. V., Обыденнов, Д. Л., & Sosnovskikh, V. Y. (2026) · Organic & Biomolecular Chemistry · doi:10.1039/d6ob00087h · Cited by 1
Extended-Release Pre-exposure Prophylaxis and Drug-Resistant HIV
Ma, Y., Kang, Y., Davenport, A. A., Aduamah, J. M., Link, K. G., & Gurski, K. F. (2024) · The IMA volumes in mathematics and its applications · doi:10.1007/978-3-031-58516-6_2 · Cited by 2
Jalili‐Nik, M., Soltani, A., Hashemy, S. I., Rafatpanah, H., Rezaee, S. A., Gorji, A., Griffith, R., & Mashkani, B. (2023) · Current Computer - Aided Drug Design · doi:10.2174/1573409919666230419082839 · Cited by 1
The mouse mammary tumor virus intasome exhibits distinct dynamics on target DNAPreprint
Baltierra‐Jasso, L. E., Jones, N. D., Ballandras-Colas, A., Engelman, A., Fishel, R. A., & Yoder, K. E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.17.468995 · Cited by 1
“Tetramer and dodecamer HIV-1 IN architectures, as well as filaments of intasomes, were observed by single particle cryogenic electron microscopy (11,22,23).”
MethodSelf-citationHerbal Medicines for HIV Infection and AIDS
Suksawat, T., & Panichayupakaranant, P. (2022) · doi:10.1002/9781119818779.ch11 · Cited by 1
Biswas, A., Choudhuri, I., Arnold, E., Lyumkis, D., Haldane, A., & Levy, R. M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.30.518575 · Cited by 1
Ortega, J. A., Sasselli, I. R., Boccitto, M., Fleming, A. C., Fortuna, T. R., Li, Y., Sato, K., Clemons, T. D., Daley, E. L., Nguyen, T. P., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.30.522259 · Cited by 1
“Force field has been widely used for simulation studies of proteins, peptides and nucleic acids (Babaian et al., 2020; Cook et al., 2020; Kognole and MacKerell, 2020; Suomivuori et al., 2020; Zhu et al., 2012).”
MethodDNA Strand Breaks and Gaps Target Retroviral Binding and IntegrationPreprint
Senavirathne, G., Gardner, A., London, J., Fishel, R. A., & Yoder, K. E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.17.469012
The KT Jeang Retrovirology prize 2021: Peter Cherepanov
Editorial, R. (2021) · Retrovirology · doi:10.1186/s12977-021-00573-1
Molecular determinants for Rous sarcoma virus intasome assembliesPreprint
Bera, S., Shi, K., Aihara, H., Grandgenett, D. P., & Pandey, K. K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.02.528060
Sun, Q., Biswas, A., Lyumkis, D., Levy, R., & Deng, N. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.29.569269
Molecular basis for the regulation of retroviral nucleosomal integration by chromatin compaction
Lapaillerie, D., Zgadzay, Y., Martins, F. G., Bertinetti, C., Autin, M., Batisse, J., Tumiotto, C., Lesbats, P., Ruff, M., Sousa, S. F., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag705
“Indeed, primate lentiviral intasomes, including HIV-1, tend to assemble in “proto-intasome stacks” of variable length composed of re-peating octameric units [ 20 , 21 ].”
Sun, Q., Aiyer, S., Biswas, A., Haldane, A., Chatterjee, S., Matubayasi, N., Lyumkis, D., & Levy, R. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.23.655847
Delineation of a novel assembly intermediate in retroviral integration pathwayPreprint
Chadda, R., Bera, S., Ghoneim, M., Melo, T. D., Grandgenett, D. P., Antony, E., & Pandey, K. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.09.675266
Cabotegravir as an HIV-1 integrase strand transfer inhibitor: from workbench to clinical development
Namasivayam, V., Vanangamudi, M., Marianesan, A. B., Guptha, P. M., & Sharma, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33885-4.00011-1
Retroviral intasome architecture shapes the dynamics of target DNA search and integration
Baltierra‐Jasso, L. E., Larue, R. C., Jones, N. D., Tan, Y. Y., Messer, R. K., Ballandras-Colas, A., Engelman, A., Fishel, R. A., & Yoder, K. E. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014070
Self-citationDelineation of a novel assembly intermediate in Rous sarcoma virus integration pathway
Chadda, R., Bera, S., Ghoneim, M., Melo, T. D., Grandgenett, D. P., Antony, E., & Pandey, K. K. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag270
HIV-1 Integrase During the Time: History of Drugs and Effort for the New Inhibitors’ Identification
Esposito, F., Saccoliti, F., Patacchini, E., & Santo, R. D. (2026) · Topics in medicinal chemistry · doi:10.1007/7355_2026_180
Identification of specific phylogenetic properties of HIV-1 M and O integrases
Toccafondi, E. (2022) · theses.fr (ABES) · doi:10.70675/2facab6ezc20az472dz8350z9fb6e718e1d4 · Cited by 1
Metadata
- Authors
- Cook, N. J., Li, W., Berta, D., Badaoui, M., Ballandras-Colas, A., Nans, A., Kotecha, A., Rosta, E., Engelman, A. N., & Cherepanov, P.
- Affiliations
- The Francis Crick Institute (GB)
- Harvard University (US)
- King's College London (GB)
- Centre for Human Genetics (GB)
- Corresponding author
- Engelman, Alan N.
- Cherepanov, Peter
- ORCID
- Venue
- Science
- Published
- 2020-02-14
- Volume
- 367
- Issue
- 6479
- Pages
- 806-810
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7023979
- OpenAlex
- W3004171189
- Cited by
- 108
- References
- 64
- Citations by year
- 2026: 12 · 2025: 11 · 2024: 18 · 2023: 18 · 2022: 16 · 2021: 20 · 2020: 13
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- National Institutes of Health (AI150481, AI070042)
- Francis Crick Institute (FC001061)
- Medical Research Council (FC001061)
- Engineering and Physical Sciences Research Council (EP/R013012/1)
- European Research Council (757850 BioNet)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- HIV integrase, integrase strand transfer inhibitors, dolutegravir, bictegravir, integrase inhibitors, drug resistance, magnesium coordination, protein-ligand binding, antiretroviral drug design
- MeSH terms
- Single Molecule Imaging, Dolutegravir, Amides, Glutamine, Glycine, Heterocyclic Compounds, 3-Ring, Heterocyclic Compounds, 4 or More Rings, Histidine, Humans, Magnesium, Mutation, Oxazines, Piperazines, Pyridones, Serine, HIV Integrase, HIV Integrase Inhibitors, Amino Acid Substitution, Catalytic Domain, Cryoelectron Microscopy, Drug Resistance, Viral
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.